Drugs / Tritanrix-HepB/Hib™
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00534833 Comparator | Sep 2007 → Sep 2008 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tritanrix-HepB/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00534833 ↗ |
| Modality | Vaccine | “booster vaccination of DTaP-HB-PRP~T or Tritanrix-HepB/Hib™” NCT00534833 ↗ |